Recent Company News

• 10:54 PM ET Aug 20, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 08:06 AM ET Aug 04, 2025
  

  Akebia initiates Vafseo (vadadustat) post-marketing study in conjunction with large dialysis Organization ($3.72, 0.00)

• 09:02 PM ET Aug 03, 2025
  

  Mitsubishi Chemical completes up-to-¥50B buyback (¥770.2000, -10.5)

• 01:43 AM ET Aug 01, 2025
  

  Mitsubishi Chemical to transfer all stake in J-Film to Marunouchi Capital; terms undisclosed (¥784.3000, -42.9)

• 12:39 AM ET Aug 01, 2025
  

  Mitsubishi Chemical reports Q1 net income attributable ¥19.63B vs year-ago ¥39.65B (¥814.4000, -12.8)

• 08:34 AM ET Jul 30, 2025
  

  NewAmsterdam Pharma presents data from BROADWAY Trial demonstrating Statistically Significant Reductions in Alzheimer's Disease Biomarkers at AAIC 2025 ($22.78, 0.00)

• 04:06 AM ET Jul 22, 2025
  

  StreetAccount Sector Preview - Japan Chemicals Apr-Jun Earnings

• 11:23 AM ET Jun 30, 2025
  

  Mineralys Therapeutics announces Journal of the American Medical Association (JAMA) publication of results from pivotal Phase III Launch-HTN trial for Lorundrostat ($13.70, -0.01)

• 06:13 PM ET Jun 26, 2025
  

  Mitsubishi Chemical resumed equal-weight at Morgan Stanley (¥744.0000, 0)

• 10:21 PM ET Jun 12, 2025
  

  Mitsubishi Tanabe Pharma doses first patient in Phase I/II study of MT-4561 in patients with advanced solid tumors in May in US (¥742.5000, -23.1)